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LETTERS TO THE EDITOR
Double Potentials Analysis as a Guide to
Radiofrequency Ablation of Atrial Flutter
We read with interest the study by Tada et al. (1) in a recent issue
of the Journal. The investigators carefully stressed the role of the
double potentials (DPs) along the ablation line as a guide to
radiofrequency ablation of typical atrial flutter. They analyzed DPs
to the site at which an application of radiofrequency energy
resulted in either a measurable slowing of conduction across the
cavo-tricuspid isthmus or complete isthmus block. These sites are
within or in close proximity to a gap in the ablation line. They
concluded that a DP1–2 interval 90 ms always indicates the
persistence of a gap in the ablation line, whereas a DP1–2 interval
110 ms always indicates the absence of a gap in the ablation line
at the recording site (1).
We believe that the absolute value of the DP1–2 interval is
limited because it depends on several factors. First: the presence of
a gap in the ablation line. A longer DP1–2 interval means higher
probability of conduction block; however, a DP1–2 interval90 ms
could be registered during conduction block at the recording site.
Second: the site of atrial pacing. If conduction block is obtained, the
DP1–2 interval lengthens as the distance of the pacing site from
recording site shortens (2). In case of persistent slow conduction
across the cavo-tricuspid isthmus, moving the pacing site along the
tricuspid annulus (TA) the DP1–2 interval remains unchanged
because the two components are linked by conduction across the
isthmus (2,3). Third: conduction velocity (CV) around the TA.
Published data indicated that in patients with atrial flutter the CV
around the TA is 37 to 42 cm/s (4), so the possible overlapping of
slowed conduction and blocked conduction values should be
evaluated. Fourth: the TA perimeter. It takes a long time for
stimulus to travel around an enlarged annulus. Fifth: linear ablation
site. The site of linear ablation (for example lateral or septal) might
have a role to determine the relative distance from the pacing site.
Sixth: drug interference. Most drugs for atrial fibrillation and
flutter slow atrial CV for which a lengthy time interval could be
referred to very slowed conduction instead of blocked conduction.
In the study by Tada et al. (1), in Figure 2, when isthmus
conduction block is obtained, the St–DP1 interval is likely 56 ms
(time for stimulus to cover about 2 cm distance); DP2, because
conduction around TA, is at 124 ms after DP1 and so St–DP2
interval is 180 ms (time for stimulus to cover about 6 cm distance
along TA perimeter). It could be that the distance from coronary
sinus ostium (CS) to linear ablation site is2 cm long (because CS
anatomy and/or lateral linear ablation) for which St–DP1 length-
ens and St–DP2 shortens (for shorter distance) and thus DP1–2
interval is 90 ms: DP1 and DP2 get near as pacing site along TA
moves away from linear ablation site.
As a reference in guiding isthmus linear ablation, it would be
useful to evaluate the hypothetical conduction time interval around
the TA in the single patient: TA cm (by echo)  CV cm/s (by
electrophysiologic study). If isthmus conduction block is obtained,
the sum of St–DP1  St–DP2 interval times corresponds to
complete conduction time interval around TA in that patient. The
St–DP1 St–DP2 interval time remains the same even if the atrial
pacing site is moved along the TA: in this case, the DP1–2 interval
lengthens as the pacing site is moved closer to the ablation line
because DP1 and DP2 are not linked. In case of slowed conduc-
tion, the sum of St–DP1  St–DP2 interval times is less than the
hypothetical conduction time interval around TA because St–DP1
and St–DP2 interval times reflect a partial conduction around TA;
if the atrial pacing site is moved along the TA, the DP1–2 interval
time does not change because DP2, instead of conducting around
TA, is linked to DP1 because of slowed conduction across the
isthmus.
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We thank Dr. Turco and colleagues for their comments. We agree
that there are several variables that may affect the interval separat-
ing the two components of double potentials recorded along an
isthmus ablation line (DP1–2 interval) that does not have any gap.
These variables account for the wide range of DP1–2 intervals
found after complete isthmus block was achieved (95 to 198 ms)
(1). Nevertheless, we continue to believe that a DP1–2 interval
110 ms is strongly associated with complete isthmus block. The
pacing site certainly affects the DP1–2 interval, and our data apply
only to proximal coronary sinus pacing.
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Decreased Incidence of Postoperative Stroke
Following Off-Pump Coronary Artery Bypass
We read with great interest the recent study by van der Linden et
al. “Postoperative Stroke in Cardiac Surgery Is Related to the
Location and Extent of Atherosclerotic Disease in the Ascending
Aorta” (1). The investigators demonstrate the importance of
routine use of epiaortic ultrasound to dictate modifications of
surgical technique during cardiac surgery in an attempt to decrease
postoperative stroke. One such modification mentioned is per-
forming coronary artery bypass grafting (CABG) without cardio-
pulmonary bypass (CPB). However, they state that “not all
surgeons are comfortable” with the techniques of off-pump coro-
nary artery bypass (OPCAB), and it appears that all 921 of their
own patients underwent conventional CABG with CPB. In recent
years technical advances in coronary artery exposure and stabiliza-
tion have resulted in a remarkable resurgence of interest in
OPCAB (2), and have ultimately led to the development of
revascularization of all coronary territories on the beating heart,
including those located in “topographically” difficult areas, includ-
ing the lateral and inferior walls of the heart (3). Currently, our
group and others perform 96% of CABG without CPB.
Postoperative stroke associated with cardiac surgery is thought
to be associated with ischemic hypoperfusion and/or cerebral
embolization. A decreased incidence of perioperative stroke has
been demonstrated if mean arterial pressure (MAP) is kept above
80 mm Hg (4). Likewise, it has also been shown that a direct
correlation exists between aortic atherosclerotic load and the
amount of cerebral embolization, likely a result of the “jet” of
perfusate through the aortic cannula scouring the atherosclerotic
aortic lumen (5). This has been corroborated in the current study
by van der Linden et al (1), who conclude that it is possible that
postoperative stroke results mainly from cerebral embolization of
atheromatous debris and not from calcified material. Therefore,
with OPCAB, avoidance of embolic potential associated with
aortic cannulation and decannulation, and the generation of
microgaseous and microparticulate emboli from the pump cir-
cuitry, significantly decreases cerebral embolic load and improves
outcomes.
Furthermore, maintenance of more normal aortic hemodynam-
ics with OPCAB and maintaining a MAP  80 mm Hg would be
expected to decrease further the incidence of cerebral atheroemboli
as well as ischemic hypoperfusion. This has been substantiated in
a study (6) showing significantly less or no cerebral emboli as
measured by transcranial Doppler in OPCAB patients in compar-
ison to those undergoing conventional CABG with CPB. In our
own experience with 269 octogenarians who underwent CABG
with the use of CPB or OPCAB techniques, we reported a
significantly lower incidence of stroke (0%, 0 of 97) in the OPCAB
group compared with an incidence of 9.3% (16 of 172) in the
conventional CABG group (7).
Until recently, in the vast majority of patients requiring surgical
coronary revascularization, performance of CABG implied the use
of CPB. Both the introduction and the progressive refinement of
myocardial stabilizer technology have greatly facilitated the devel-
opment of OPCAB. It is currently estimated that approximately
20% of the 600,000 CABG procedures performed annually in the
U.S. are done using OPCAB techniques; this number is predicted
to grow substantially over the next decade (8). The study by van
der Linden et al. (1) is extremely relevant in identifying the
location and extent of atherosclerotic disease in the ascending aorta
as a risk factor for postoperative stroke following cardiac surgery.
However, we believe that their 3.5% incidence of stroke by using
epiaortic ultrasound may be further reduced in high-risk patients
by using OPCAB techniques. Independent of the cost, complexity
and the high degree of technical support associated with CPB,
there has been steadily mounting evidence of some degree of
end-organ dysfunction associated with its usage (9). For a majority
of patients, this manifests in clinically undetectable sequelae, but
for a significant minority, the neurologic results are devastating.
Therefore, we recommend the routine use of OPCAB techniques
in all high-risk patients, especially those with atherosclerotic
disease of the ascending aorta.
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